169 related articles for article (PubMed ID: 32345134)
1. Recent Use of Synthetic Cannabinoids, Synthetic Opioids, and Other Psychoactive Drug Groups among High-risk Drug Users.
Shapira B; Berkovitz R; Rosca P; Neumark Y
J Psychoactive Drugs; 2020; 52(4):334-343. PubMed ID: 32345134
[TBL] [Abstract][Full Text] [Related]
2. Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?
Smith KE; Staton M
Subst Abus; 2019; 40(2):160-169. PubMed ID: 30457960
[No Abstract] [Full Text] [Related]
3. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.
Shapira B; Rosca P; Berkovitz R; Gorjaltsan I; Neumark Y
PeerJ; 2020; 8():e9461. PubMed ID: 32742781
[TBL] [Abstract][Full Text] [Related]
4. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs.
Kozak Z; Urquhart GJ; Rouhani S; Allen ST; Park JN; Sherman SG
Am J Addict; 2024 Jan; 33(1):83-91. PubMed ID: 37717256
[TBL] [Abstract][Full Text] [Related]
6. Illicitly Manufactured Fentanyl Use Among Individuals in the U.S., 2022.
Palamar JJ
Am J Prev Med; 2024 Mar; ():. PubMed ID: 38527696
[TBL] [Abstract][Full Text] [Related]
7. Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California.
Wagner KD; Armenta RF; Roth AM; Maxwell JC; Cuevas-Mota J; Garfein RS
Drug Alcohol Depend; 2014 Aug; 141():99-106. PubMed ID: 24916748
[TBL] [Abstract][Full Text] [Related]
8. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Cannabinoid-Related Deaths in England, 2012-2019.
Yoganathan P; Claridge H; Chester L; Englund A; Kalk NJ; Copeland CS
Cannabis Cannabinoid Res; 2022 Aug; 7(4):516-525. PubMed ID: 33998886
[No Abstract] [Full Text] [Related]
10. Fatal Poisonings Associated with New Psychoactive Substances.
Kronstrand R; Guerrieri D; Vikingsson S; Wohlfarth A; Gréen H
Handb Exp Pharmacol; 2018; 252():495-541. PubMed ID: 30105471
[TBL] [Abstract][Full Text] [Related]
11. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
[TBL] [Abstract][Full Text] [Related]
12. Trends and correlated outcomes in population-level prescription opioid and transdermal fentanyl use in Israel.
Shapira B; Berkovitz R; Haklai Z; Goldberger N; Lipshitz I; Rosca P
Isr J Health Policy Res; 2023 Mar; 12(1):9. PubMed ID: 36941731
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
[TBL] [Abstract][Full Text] [Related]
14. Risk-factors for continuous long-term use of prescription opioid drugs 3 years after hysterectomy: A nationwide cohort study.
Brunes M; Häbel H; Altman D; Ek M
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1057-1063. PubMed ID: 32053212
[TBL] [Abstract][Full Text] [Related]
15. Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones.
Patrick ME; O'Malley PM; Kloska DD; Schulenberg JE; Johnston LD; Miech RA; Bachman JG
Drug Alcohol Rev; 2016 Sep; 35(5):586-90. PubMed ID: 26711540
[TBL] [Abstract][Full Text] [Related]
16. Marijuana users are likely to report opioid misuse among adults over 50 years in representative sample of the United States (2002-2014).
Ramadan MM; Banta JE; Bahjri K; Montgomery SB
J Addict Dis; 2021; 39(1):66-73. PubMed ID: 32935646
[No Abstract] [Full Text] [Related]
17. Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin.
Pergolizzi JV; LeQuang JA; Taylor R; Raffa RB;
Postgrad Med; 2018 Jan; 130(1):1-8. PubMed ID: 29190175
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and Mass Loading of Synthetic Opioids, Synthetic Cathinones, and Synthetic Cannabinoids in Wastewater Treatment Plants in Four U.S. Communities.
O'Rourke CE; Subedi B
Environ Sci Technol; 2020 Jun; 54(11):6661-6670. PubMed ID: 32356976
[TBL] [Abstract][Full Text] [Related]
19. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study.
Jani M; Birlie Yimer B; Sheppard T; Lunt M; Dixon WG
PLoS Med; 2020 Oct; 17(10):e1003270. PubMed ID: 33057368
[TBL] [Abstract][Full Text] [Related]
20. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
